The gefitinib dose reduction on survival outcomes in epidermal growth factor receptor mutant non-small cell lung cancer
Purpose Gefitinib is safe for the treatment of non-small cell lung cancer (NSCLC), but some
patients experience toxicities and require dose reduction. The purpose of this study was to …
patients experience toxicities and require dose reduction. The purpose of this study was to …
The gefitinib dose reduction on survival outcomes in epidermal growth factor receptor mutant non-small cell lung cancer
SH Sim, B Keam, DW Kim, TM Kim… - Journal of Cancer …, 2014 - snucm.elsevierpure.com
Results: Of the 263 patients, 23 had gefitinib dose reduction due to toxicities (1 due to
mucositis, 5 due to skin rash, 11 due to hepatotoxicity and 6 for both skin and hepatotoxicity) …
mucositis, 5 due to skin rash, 11 due to hepatotoxicity and 6 for both skin and hepatotoxicity) …
The gefitinib dose reduction on survival outcomes in epidermal growth factor receptor mutant non-small cell lung cancer
SH Sim, B Keam, DW Kim, TM Kim… - Journal of cancer …, 2014 - pubmed.ncbi.nlm.nih.gov
Purpose Gefitinib is safe for the treatment of non-small cell lung cancer (NSCLC), but some
patients experience toxicities and require dose reduction. The purpose of this study was to …
patients experience toxicities and require dose reduction. The purpose of this study was to …
The gefitinib dose reduction on survival outcomes in epidermal growth factor receptor mutant non-small cell lung cancer
SH Sim, B Keam, DW Kim, TM Kim, SH Lee… - Journal of Cancer …, 2014 - infona.pl
Purpose Gefitinib is safe for the treatment of non-small cell lung cancer (NSCLC), but some
patients experience toxicities and require dose reduction. The purpose of this study was to …
patients experience toxicities and require dose reduction. The purpose of this study was to …
[引用][C] The gefitinib dose reduction on survival outcomes in epidermal growth factor receptor mutant non-small cell lung cancer
SH Sim, B Keam, DW Kim, TM Kim, SH Lee… - Journal of Cancer …, 2014 - cir.nii.ac.jp
The gefitinib dose reduction on survival outcomes in epidermal growth factor receptor mutant
non-small cell lung cancer | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ …
non-small cell lung cancer | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ …
The gefitinib dose reduction on survival outcomes in epidermal growth factor receptor mutant non-small cell lung cancer
SH Sim, B Keam, DW Kim, TM Kim… - Journal of Cancer …, 2014 - s-space.snu.ac.kr
Gefitinib is safe for the treatment of non-small cell lung cancer (NSCLC), but some patients
experience toxicities and require dose reduction. The purpose of this study was to evaluate …
experience toxicities and require dose reduction. The purpose of this study was to evaluate …
The gefitinib dose reduction on survival outcomes in epidermal growth factor receptor mutant non-small cell lung cancer.
S Sim, B Keam, DW Kim, T Kim… - Journal of Cancer …, 2014 - search.ebscohost.com
Purpose: Gefitinib is safe for the treatment of non-small cell lung cancer (NSCLC), but some
patients experience toxicities and require dose reduction. The purpose of this study was to …
patients experience toxicities and require dose reduction. The purpose of this study was to …
The gefitinib dose reduction on survival outcomes in epidermal growth factor receptor mutant non-small cell lung cancer.
SH Sim, B Keam, DW Kim, TM Kim, SH Lee… - Journal of Cancer …, 2014 - europepmc.org
Purpose Gefitinib is safe for the treatment of non-small cell lung cancer (NSCLC), but some
patients experience toxicities and require dose reduction. The purpose of this study was to …
patients experience toxicities and require dose reduction. The purpose of this study was to …
The gefitinib dose reduction on survival outcomes in epidermal growth factor receptor mutant non-small cell lung cancer
SH Sim, B Keam, DW Kim, TM Kim… - Journal of Cancer …, 2014 - search.proquest.com
Purpose Gefitinib is safe for the treatment of non-small cell lung cancer (NSCLC), but some
patients experience toxicities and require dose reduction. The purpose of this study was to …
patients experience toxicities and require dose reduction. The purpose of this study was to …